Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1003

1.

Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.

Nelson JC, Mazure CM, Jatlow PI, Bowers MB Jr, Price LH.

Biol Psychiatry. 2004 Feb 1;55(3):296-300.

PMID:
14744472
[PubMed - indexed for MEDLINE]
2.

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action.

Delgado PL, Miller HL, Salomon RM, Licinio J, Krystal JH, Moreno FA, Heninger GR, Charney DS.

Biol Psychiatry. 1999 Jul 15;46(2):212-20.

PMID:
10418696
[PubMed - indexed for MEDLINE]
3.

Noradrenaline-selective versus serotonin-selective antidepressant therapy: differential effects on social functioning.

Dubini A, Bosc M, Polin V.

J Psychopharmacol. 1997;11(4 Suppl):S17-23.

PMID:
9438229
[PubMed - indexed for MEDLINE]
4.

Do depressed subjects who have failed both fluoxetine and a tricyclic antidepressant respond to the combination?

Levitt AJ, Joffe RT, Kamil R, McIntyre R.

J Clin Psychiatry. 1999 Sep;60(9):613-6.

PMID:
10520980
[PubMed - indexed for MEDLINE]
5.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
6.

Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.

Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ; Comparative Efficacy Antidepressants Study Group.

CNS Drugs. 2005;19(2):137-46.

PMID:
15697327
[PubMed - indexed for MEDLINE]
7.

Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study.

Appelberg BG, Syvälahti EK, Koskinen TE, Mehtonen OP, Muhonen TT, Naukkarinen HH.

J Clin Psychiatry. 2001 Jun;62(6):448-52.

PMID:
11465522
[PubMed - indexed for MEDLINE]
8.

Concurrent treatment of nonresistant major depression with desipramine and lithium: a double-blind, placebo-controlled study.

Bloch M, Schwartzman Y, Bonne O, Lerer B.

J Clin Psychopharmacol. 1997 Feb;17(1):44-8.

PMID:
9004056
[PubMed - indexed for MEDLINE]
9.

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment.

Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F.

Lancet. 1997 May 31;349(9065):1594-7.

PMID:
9174562
[PubMed - indexed for MEDLINE]
10.

Reboxetine versus fluoxetine: an overview of efficacy and tolerability.

Massana J.

J Clin Psychiatry. 1998;59 Suppl 14:8-10.

PMID:
9818624
[PubMed - indexed for MEDLINE]
11.

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial.

Freeman EW, Rickels K, Sondheimer SJ, Polansky M.

Arch Gen Psychiatry. 1999 Oct;56(10):932-9.

PMID:
10530636
[PubMed - indexed for MEDLINE]
12.

Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.

Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G.

Eur Neuropsychopharmacol. 2009 Jul;19(7):457-65. doi: 10.1016/j.euroneuro.2009.01.015. Epub 2009 Apr 2.

PMID:
19345072
[PubMed - indexed for MEDLINE]
13.

Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.

Simon GE, Heiligenstein J, Revicki D, VonKorff M, Katon WJ, Ludman E, Grothaus L, Wagner E.

Arch Fam Med. 1999 Jul-Aug;8(4):319-25.

PMID:
10418538
[PubMed - indexed for MEDLINE]
14.

Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.

Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.

J Clin Psychiatry. 2010 Apr;71(4):451-62. doi: 10.4088/JCP.08m04984gre. Epub 2010 Feb 23.

PMID:
20361905
[PubMed - indexed for MEDLINE]
15.

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.

Stahl SM, Entsuah R, Rudolph RL.

Biol Psychiatry. 2002 Dec 15;52(12):1166-74.

PMID:
12488062
[PubMed - indexed for MEDLINE]
16.

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

Bielski RJ, Ventura D, Chang CC.

J Clin Psychiatry. 2004 Sep;65(9):1190-6.

PMID:
15367045
[PubMed - indexed for MEDLINE]
17.

Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.

Roose SP, Laghrissi-Thode F, Kennedy JS, Nelson JC, Bigger JT Jr, Pollock BG, Gaffney A, Narayan M, Finkel MS, McCafferty J, Gergel I.

JAMA. 1998 Jan 28;279(4):287-91.

PMID:
9450712
[PubMed - indexed for MEDLINE]
18.

Long-term efficacy and safety of milnacipran compared to clomipramine in patients with major depression.

Leinonen E, Lepola U, Koponen H, Mehtonen OP, Rimon R.

Acta Psychiatr Scand. 1997 Dec;96(6):497-504.

PMID:
9421348
[PubMed - indexed for MEDLINE]
19.

Noradrenergic versus serotonergic antidepressants: predictors of treatment response.

Schatzberg AF.

J Clin Psychiatry. 1998;59 Suppl 14:15-8. Review.

PMID:
9818626
[PubMed - indexed for MEDLINE]
20.

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders.

Hoehn-Saric R, Ninan P, Black DW, Stahl S, Greist JH, Lydiard B, McElroy S, Zajecka J, Chapman D, Clary C, Harrison W.

Arch Gen Psychiatry. 2000 Jan;57(1):76-82.

PMID:
10632236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk